News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News Vast Majority of HFrEF Patients Eligible for Vericiguat L.A. McKeown February 08, 2023
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Daily News VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint Todd Neale November 20, 2019